Загрузка...
Gene Therapy with MiRNA-Mediated Targeting of Mcl-1 Promotes the Sensitivity of Non-Small Cell Lung Cancer Cells to Treatment with ABT-737
BACKGROUND: Despite the dramatic efficacy of ABT-737, a large percentage of cancer cells ultimately become resistance to this drug. Evidences show that over-expression of Mcl-1 is linked to ABT-737 resistance in NSCLC cells. The aim of this study was to investigate the effect of miRNA-101 on Mcl-1 e...
Сохранить в:
| Опубликовано в: : | Asian Pac J Cancer Prev |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
West Asia Organization for Cancer Prevention
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437340/ https://ncbi.nlm.nih.gov/pubmed/32212793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.3.675 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|